It’s impossible for us to pinpoint the first instance of advertising in human history, but we imagine that as soon as people began exchanging currency for goods, someone had the idea of putting out a sign to get the attention of customers. For most of our history since that point, advertising has been all about reaching as many people as possible with a message and hoping that a few people respond to it. That’s all changing now, though, and the idea of a new, targeted marketing approach is one that can revolutionize the way you seek patient enrollment in clinical trials.

Casting a Wide Net

Most big steps forward in the field of advertising have been developments that made it possible to reach far more people than ever before. Radio was one of these developments, as was television. Even many modern tools like Twitter are popular because they offer maximum exposure for minimal costs. But today, the goal of smart marketers is not reaching more people, but reaching the right people.

More Information Equals More Efficiency

Never before has it been possible for businesses to efficiently develop a mailing list consisting of only those people who are highly likely to respond to their advertisements. Data gathering and management technology, though, has made this the new frontier of marketing. Services like Facebook, which request detailed information from users, are gold mines for advertisers interested in reaching the elderly, parents of young children, or nearly any other demographic group.

Patient Enrollment in Clinical Trials

We bring the power of targeted marketing to the field of patient enrollment in clinical trials with a huge database of self-reported names, each of whom has expressed interest in participating in clinical trials. As we work with you and identify the indication you are testing for, we filter by race, age, gender, and other factors to get you the most targeted mailing list possible—meaning a much higher rate of response than other marketing methods.